Meet Our Co-Editor

Author(s): Mark S. Gold

Journal Name: Current Psychopharmacology

Volume 10 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

[1]
Blum K, Khalsa J, Cadet JL, Baron D, Bowirrat A, Boyett B, et al. Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. Front Psychiatry 2021; 12.
[2]
Blum K, Kazmi S, Modestino EJ, Downs BW, Bagchi D, Baron D, et al. A novel precision approach to overcome the “addiction pandemic” by incorporating genetic addiction risk severity (Gars) and dopamine homeostasis restoration. J Pers Med 2021; 11(3)
[3]
Blum K, Cadet JL, Gold MS. Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. J Neurol Sci 2021; 420.
[4]
Moran M, Blum K, Ponce JV, Lott L, Gondré–Lewis MC, Badgaiyan S, et al. High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial. Mol Neurobiol 2021.
[5]
Oesterle TS, Kolla B, Risma CJ, Breitinger SA, Rakocevic DB, Loukianova LL, et al. Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Mayo Clin Proc 2020; 95(12): 2709-18.
[6]
Gold MS, Baron D, Bowirrat A, Blum K. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? J Neurol Sci 2020; 418.
[7]
Wiss DA, Avena N, Gold M. Food addiction and psychosocial adversity: Biological embedding, contextual factors, and public health implications. Nutrients 2020; 12(11): 1-26.
[8]
Blum K, Cadet JL, Baron D, Badgaiyan RD, Brewer R, Modestino EJ, et al. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword? Subst Use Misuse 2020; 55(14): 2438-42.
[9]
Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PK. The therapeutic potential of exercise for neuropsychiatric diseases: A review. J Neurol Sci 2020; 412.
[10]
Patterson Silver Wolf DA, Gold M. Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. J Neurol Sci 2020; 411.
[11]
Oesterle TS, Kolla BP, Rummans TA, Gold MS. Medication-assisted therapies for opioid use disorders in patients with chronic pain. J Neurol Sci 2020; 411.
[12]
Blum K, Baron D, McLaughlin T, Gold MS. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS). J Neurol Sci In: 2020; 411.
[13]
Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Infectious diseases occurring in the context of substance use disorders: A concise review. J Neurol Sci 2020; 411.
[14]
El Hayek S, Allouch F, Razafsha M, Talih F, Gold MS, Wang KK, et al. Traumatic brain injury and methamphetamine: A double-hit neurological insult. J Neurol Sci 2020; 411.
[15]
Haidar MA, Jourdi H, Haj Hassan Z, Ashekyan O, Fardoun M, Wehbe Z, et al. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist 2020.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 10
ISSUE: 2
Year: 2021
Published on: 02 November, 2021
Page: [85 - 85]
Pages: 1
DOI: 10.2174/221155601002210517123521

Article Metrics

PDF: 484
HTML: 2